At a glance
| What it is | Cosmetic ingredient, a collagen-inspired signal peptide |
| FDA status | As a cosmetic ingredient rather than a drug, does not require FDA approval |
| Research | Activity supported mainly by laboratory and manufacturer data |
| Main uses | Products targeting the look of firmness, smoother texture, and fine lines |
| Evidence strength | Low research |
What is hexapeptide-9?
Hexapeptide-9 is a peptide of six amino acids whose sequence mirrors a short motif found in human collagen, the protein that gives skin its structure. In skincare it is used as a "signal" or messenger peptide, meant to prompt skin cells rather than to add collagen directly. It is sold under trade names such as Collaxyl and is a cosmetic ingredient, not a drug.
How does it work?
Laboratory studies describe hexapeptide-9 as a matrikine, a peptide fragment that acts as a signal to skin cells. The proposed mechanism is that it tells dermal fibroblasts and surface keratinocytes to increase production of extracellular matrix components such as collagen, as well as to strengthen the junction between the upper and lower layers of skin. The idea is that healthier-looking matrix supports the appearance of firmer, smoother skin. These are laboratory and manufacturer findings about how the peptide behaves in cell models. In finished cosmetics the benefit is described in appearance terms, such as the look of firmness and reduced fine lines, rather than as a claim to rebuild collagen.
Is it FDA-approved?
No, and it does not need to be. The FDA does not pre-approve cosmetic ingredients. A cosmetic may describe how it affects the look and feel of skin, while a claim to change the body's structure would make a product a drug. Hexapeptide-9 is used within the cosmetic boundary, for the appearance of the skin.
What is it used for?
Hexapeptide-9 is used in "anti-aging" and firming serums and creams. The appearance goals are the look of firmer skin, improved texture and tone, and a reduction in the appearance of fine lines. It is often paired with other peptides and hydrating ingredients.
What does the research show?
The direct human evidence is limited:
- According to PubMed, a randomized, controlled trial reported wrinkle improvements, but it tested a cyclized derivative of the molecule rather than standard hexapeptide-9, and it was industry-sponsored.
- Other studies use the peptide inside delivery systems or combination products, so the ingredient's individual effect is hard to isolate.
- There is no independent, well-controlled human trial of standard hexapeptide-9 on its own, and supplier efficacy claims are largely unpublished.
What are the side effects?
Hexapeptide-9 is generally considered well tolerated on the skin, with low irritation potential at cosmetic use levels. As with any new skincare ingredient, a patch test is sensible for sensitive or reactive skin, since individual responses vary.
Evidence strength
Low research: The ingredient's rationale rests on laboratory and manufacturer data, and the only controlled human study tested a modified version rather than standard hexapeptide-9, so there is no sound human evidence for the ingredient itself.
Sources: a randomized controlled trial of a cyclized hexapeptide-9 derivative (Chang et al., Journal of Cosmetic Dermatology, 2025, DOI: 10.1111/jocd.70290), indexed on PubMed; and cosmetic ingredient reference data on hexapeptide-9. This document is educational and does not constitute medical advice.

















